Skip to main content
Year archive

AngioLab, Inc. — 2024 filings

All 17 regulatory filings released by AngioLab, Inc. (251280) in 2024, sourced directly from the official regulator.

17 Filings
2024 Period
2024 filings (17)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2024-12-13 Korean
기업설명회(IR)개최결과
Regulatory Filings
2024-11-14 Korean
임상시험단계진입ㆍ종료(자율공시) (습성황반변성 치료제 ALS-L1023의 임상 3상 시험계획 (IND)에 대한 식약처 승인)
Legal Proceedings Report
2024-09-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-04-29 Korean
기업설명회(IR)개최결과
Regulatory Filings
2024-04-22 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2024-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2024-03-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2024-03-27 Korean
감사보고서제출
Audit Report / Information FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report FY 2023
2024-03-20 Korean
주주총회소집공고
AGM Information
2024-03-13 Korean
주주총회소집결의
AGM Information
2024-03-08 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2024-02-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2024-02-14 Korean
[기재정정]기타주요경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2024-01-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2024-01-15 Korean
기타주요경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2024-01-12 Korean